Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Carboplatin 28 Cisplatin 25 pembrolizumab 25 Paclitaxel 22 Nivolumab 20 Gemcitabine 17 Pemetrexed 15 Rituximab 14 Ipilimumab 13 Cyclophosphamide 11 Dexamethasone 11 Fluorouracil 10 durvalumab 10 Capecitabine 9 Docetaxel 9 trastuzumab deruxtecan 9 Lenalidomide 8 Oxaliplatin 8 atezolizumab 8 Doxorubicin 7 daratumumab 7 osimertinib 7 Bortezomib 6 Cytarabine 6 Leucovorin 6 Sunitinib 6 Trastuzumab 6 olaparib 6 venetoclax 6 130-nm albumin-bound paclitaxel 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × darlin protein, Dictyostelium × 1 year × Clear all

NCT03180736 2025-12-19

EMN14

European Myeloma Network B.V.

Phase 3 Completed

304 enrolled 19 charts 1 FDA

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡